Stock E2O STRATA SKIN SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings STRATA Skin Sciences, Inc. Deutsche Boerse AG

Equities

E2O

US86272A3059

Market Closed - Deutsche Boerse AG
Other stock markets
 08:02:20 06/06/2024 BST 		5-day change 1st Jan Change
3.76 EUR +24.50% Intraday chart for STRATA Skin Sciences, Inc. -.--% -22.95%
05-15 STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-15 Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
STRATA SKIN SCIENCES, INC. Stock STRATA Skin Sciences, Inc.
-22.95% 10.55M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+0.59% 207B
B
DANAHER CORPORATION Stock Danaher Corporation
+3.92% 181B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+30.07% 155B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.42% 112B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.98% 64.42B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.65% 54.38B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.86% 47.43B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-9.53% 37.17B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-1.28% 34.81B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SSKN Stock
  4. E2O Stock
  5. Ratings STRATA Skin Sciences, Inc.